Abstract:Esophageal squamous cell neoplasm (ESCN), the most common secondary tumor among patients with head and neck squamous cell carcinoma (HNSCC), occurs at a rate of 3%–10% [1] [2]. The occurrence of second primary tumors (SPTs) is one of the major reasons for the lower survival rates in HNSCC patients [3]. High risk factors associated with SPT occurrence have also been identified [3]. In a prospective study conducted by van Tilburg et al., synchronous or metachronous endoscopic screenings were performed in patients with a history of HNSCC, leading to the identification of SPTs in 5% of patients [4]. This research serves as a reminder for endoscopists to enhance their vigilance in observing abnormal lesions in the pharynx and larynx during endoscopic examinations, while also recognizing the importance of timely communication and collaboration with otolaryngologist. In the van Tilburg et al. study, various imaging modalities, including computed tomography, nasal endoscopy, magnetic resonance imaging, and endoscopy, were used to monitor the occurrence of SPTs following HNSCC [4]. With the rapid development of artificial intelligence today, it is possible to collect diverse imaging data from patients with HNSCC who are at risk of developing SPTs, and to utilize artificial intelligence and machine learning to construct predictive models for related risks. Moreover, microscopic approaches such as microbiome sequencing, blood miRNA detection, and spatial-temporal transcriptomics could be employed to establish multiomic analysis for early prediction of asynchronous or multiple primary cancers. Additionally, we noted that the exclusion criteria of the study included patients with pharyngeal cancer preceding or concurrent with esophageal cancer [4]. If a risk model were constructed for this subset of patients, it might enable comprehensive prediction of the temporal and spatial sequence of tumor development, including HNSCC. Such comprehensive research would be of significant clinical value, and we eagerly anticipate witnessing such advancements in the future. It would undoubtedly create a groundbreaking impact on the progress of human medicine. Article published online: 30 January 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Screening and surveillance of esophageal cancer by magnifying endoscopy with narrow band imaging improves the survival of hypopharyngeal cancer patients

Diagnostic performance of magnifying narrow-band imaging for early gastric cancer: A meta-analysis

Clinical benefits from endoscopy screening of esophageal second primary tumor for head and neck cancer patients: Analysis of a hospital-based registry

Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis

Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients

Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients

Image-enhanced endoscopy for detection of second primary esophageal neoplasms in patients with hypopharyngeal cancer: Prevalence, risk factors, and characteristics

Diagnostic Ability of Magnifying Narrow-Band Imaging for the Extent of Early Gastric Cancer: A Systematic Review and Meta-Analysis

Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients

Usefulness of non-magnifying narrow-band imaging in screening of early esophageal squamous cell carcinoma: a prospective comparative study using propensity score matching

Effect of adding magnifying BLI, magnifying NBI, and iodine staining to white light imaging in diagnosis of early esophageal cancer

Unveiling the hidden threat: esophageal squamous cell neoplasm in patients with head and neck squamous cell carcinoma

Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes

Tolerability of magnifying narrow band imaging endoscopy for esophageal cancer screening

Efficacy of magnifying endoscopy combined with narrowband imaging in detection of early gastric cancer: a systematic evaluation and meta-analysis

Tu1305 Endoscopic Surveillance Comparing Narrow Band Imaging (NBI) Against Lugol Chromoendoscopy for Detection of Synchronous Superficial Squamous Esophageal Neoplasia Among High Risk Patients

Evaluation of the safety and effectiveness of neoadjuvant combined chemoimmunotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective single-arm cohort study

Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients

Application of Narrow Band Imaging Combined with Lugol Chromo-Endoscopy in the Diagnosis of Advanced Esophageal Carcinoma

AI-assisted Identification of Intrapapillary Capillary Loops in Magnification Endoscopy for Diagnosing Early-Stage Esophageal Squamous Cell Carcinoma: a Preliminary Study

Detection of pharyngeal cancer in the overall population undergoing upper GI endoscopy by using narrow-band imaging: a single-center experience, 2009-2012